We report that perospirone may have had positive effects on the obesity of three patients with schizophrenia and on the fasting blood sugar (FBS) and HbA1C of two of them who had type 2 diabetes mellitus.
|Number of pages||3|
|Journal||International Clinical Psychopharmacology|
|Publication status||Published - 2004 Jan 1|
- Diabetes mellitus
ASJC Scopus subject areas
- Psychiatry and Mental health
- Pharmacology (medical)